ERBB2 c.1963_1964delinsGC ;(p.I655A)

Variant ID: 17-37879588-AT-GC

NM_004448.2(ERBB2):c.1963_1964delinsGC;(p.I655A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Genetic Influences in Breast Cancer Drug Resistance.

Breast Cancer (Dove Medical Press)
Daniyal, Adhitiya A; Santoso, Ivana I; Gunawan, Nadira Hasna Putri NHP; Barliana, Melisa Intan MI; Abdulah, Rizky R
Publication Date: 2021

Variant appearance in text: HER2: I655A
PubMed Link: 33603458
Variant Present in the following documents:
  • Main text
  • bctt-13-59.pdf
View BVdb publication page



A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.

Investigational New Drugs
Falchook, Gerald S GS; Moulder, Stacy S; Naing, Aung A; Wheler, Jennifer J JJ; Hong, David S DS; Piha-Paul, Sarina A SA; Tsimberidou, Apostolia M AM; Fu, Siqing S; Zinner, Ralph R; Janku, Filip F; Jiang, Yunfang Y; Huang, Mei M; Parkhurst, Kristin L KL; Kurzrock, Razelle R
Publication Date: 2015-02

Variant appearance in text: HER2: I655A
PubMed Link: 25323060
Variant Present in the following documents:
  • Main text
View BVdb publication page



The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean population.

Bmc Cancer
Jo, Uk Hyun UH; Han, Sle Gi Lo SG; Seo, Jae Hong JH; Park, Kyong Hwa KH; Lee, Jae Won JW; Lee, Hyo Jung HJ; Ryu, Jeong Seon JS; Kim, Yeul Hong YH
Publication Date: 2008-12-04

Variant appearance in text: HER-2: I655A
PubMed Link: 19055823
Variant Present in the following documents:
  • Main text
  • 1471-2407-8-359.pdf
View BVdb publication page